Vyepti 100 mg/1 ml
Vyepti 100 mg/1 ml is a medicine authorised by Swissmedic under authorisation number 67995. The authorisation holder is Lundbeck (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 October 2021 and the authorisation is valid without a time limit. ATC code N02CD05 places the medicine in the group Analgesics.
| Authorisation number | 67995 |
|---|---|
| Name | Vyepti 100 mg/1 ml |
| Full name | Vyepti 100 mg/1 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Lundbeck (Schweiz) AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | N02CD05 |
| First authorisation | 11 October 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Vyepti 100 mg/1 ml, Konzentrat zur Herstellung einer Infusionslösung | B | 11 October 2021 |
| 2 | Vyepti 300 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung | B | 13 August 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 1 ml | Durchstechflasche(n) | N02CD05 | 02.05.1. | B |
| 2 | 1 x 3 ml | Durchstechflasche(n) | N02CD05 | 02.05.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Vyepti 100 mg/1 ml authorised in Switzerland?
Yes. Vyepti 100 mg/1 ml is authorised by Swissmedic under authorisation number 67995, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Vyepti 100 mg/1 ml have?
Vyepti 100 mg/1 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Vyepti 100 mg/1 ml?
The authorisation holder is Lundbeck (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.